-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/high-risk-drugs-protocol.pdf
July 27, 2023 - Protocol
Project Title: Making Healthcare Safer IV:
Protocols for High-Risk Drugs: Reducing Adverse Drug … The “Protocols for High-Risk Drugs:
Reducing Adverse Drug Events Related to Anticoagulants” as a patient … Event
Prevention (ADE Action Plan) identified anticoagulants as a leading cause of adverse
drug … cause-specific mortality, bleeding,
hemorrhage, stroke, quality of life, adverse
events associated with drug-drug … US
Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
October 01, 2014 - Mifepristone, a drug for psychotic major depression (PMD), a
condition for which no U.S. … administration and
is known to be a street drug of abuse. … Research suggests new drug targets for
depression. … Food and Drug Administration
(FDA) [accessed 2012 Mar 15]. [2 p]. … Washington (DC): Drug
Enforcement Administration, U.S.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
June 01, 2022 - Reviews, PsycINFO®, and Scopus from September 2, 2021 to December 30, 2021.We also
searched Food and Drug … Placebo
From the previous report,
NSAIDs as a drug class,
compared with placebo,
resolved pain at … No change in SOE
supporting the
effect of NSAIDs as
a drug class vs. … analyses
Abbreviations: KQ = Key Question; mg = milligram; NSAID = nonsteroidal anti-inflammatory drug … Therapy]
24 exp Vomiting/dt [Drug Therapy]
25 (((drug* or agent* or medication*) adj3 (nausea or
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
July 01, 2014 - A vs. drug B)? … Using a second drug to augment the effects of the
primary drug and comparing this treatment with
monotherapy … with a single drug
ii. … A
vs. drug B)? … Using a second drug to augment the effects of the
primary drug and comparing this treatment with
monotherapy
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/depression-pregnancy-postpartum_research-protocol.pdf
March 29, 2013 - A vs. drug B)? … Using a second drug to augment the effects of the primary drug and comparing
this treatment with monotherapy … with a single drug
ii. … A vs. drug B)? … The
combination include:
(a) Using a second drug to augment the effects of the primary drug and
-
effectivehealthcare-admin.ahrq.gov/products/depression-pregnancy-postpartum/research-protocol
March 29, 2013 - that are compared with drug only interventions. … A vs. drug B)? … The combinations include:
Using a second drug to augment the effects of the primary drug and comparing … A vs. drug B)? … The combination include:
(a) Using a second drug to augment the effects of the primary drug and comparing
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_executive.pdf
September 19, 2014 - *Including opioid management plans, patient education, urine drug screening, use of prescription drug … The DAWN Report: Highlights of the
2010 Drug Abuse Warning Network (DAWN) Findings on
Drug-Related … Food and Drug Administration. … Food and Drug Administration. … Does
random urine drug testing reduce illicit drug use in
chronic pain patients receiving opioids?
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/clifford.pdf
January 06, 2017 - So you can look and you can say, OK, what drug are they taking. They're
taking Gabapentin. … amount of additional information about the
utilization of that drug in the real world. … So it limits misattribution of things like nausea if someone's taking a
drug and saying, OK, you know … What's the likelihood that
my nausea today is being caused by this drug? … We had 10 times as many people on drug and 30 times as many controls in our
trial, in observational
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
January 01, 2005 - Does product discuss harm and benefit of treatment with the drug? … Guidelines for Diagnosis and Management of Osteoporosis in Canada (2002)
Osteoporosis Canada Website, “Drug … increased risk of cardiovascular disease, their families and the public
Canada
Osteoporosis Canada
“Drug … www.osteoporosis.ca
Osteoporosis Canada:
About Osteoporosis--Drug Treatments
Appropriate … comparison of alternatives Yes, both discussed, but not in detail Yes,
Explore with doctor and find best drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
November 01, 2008 - Adverse drug
reactions: definitions, diagnosis, and
management. … Center for
Drug Evaluation and Research. … Adverse
drug reactions: keeping up to date. … The Research on Adverse Drug Events and
Reports (RADAR) project. … Adverse
reaction/adverse drug
reaction
An adverse effect specifically associated with a drug.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
November 01, 2008 - Adverse drug
reactions: definitions, diagnosis, and
management. … Center for
Drug Evaluation and Research. … Adverse
drug reactions: keeping up to date. … The Research on Adverse Drug Events and
Reports (RADAR) project. … Adverse
reaction/adverse drug
reaction
An adverse effect specifically associated with a drug.
-
effectivehealthcare-admin.ahrq.gov/products/mhs4-opioid-stewardship/rapid-research
December 20, 2023 - Making Healthcare Safer IV: Active Infection Surveillance of Clostridioides difficile and Multi-Drug … | Sep 7, 2023
Making Healthcare Safer IV: Prevention of Transmission of Infection With Multi-Drug … Improve the Safety of Surgical Care
Rapid Evidence Product | Jan 16, 2024
Reducing Adverse Drug … | Feb 9, 2024
Computerized Clinical Decision Support To Prevent Medication Errors and Adverse Drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/depression_hi_impact.pdf
October 01, 2014 - Food and Drug
Administration (FDA) approval of any DBS device for a psychiatric indication. … DBS is indicated to complement conventional drug
therapy for MDD or OCD. … dosages or different drug regimens. … The drug different effect size was largest at day 2. … Food and Drug Administration (FDA); 2010
Apr 1 [accessed 2011 May 23]. [19 p].
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
January 01, 2012 - A drug for psychotic major
depression (PMD), for which the U.S. … administration and is known to
be a street drug of abuse. … Research suggests new drug targets for
depression. … Food and Drug Administration
(FDA) [accessed 2012 Mar 15]. [2 p]. … Washington (DC): Drug
Enforcement Administration, U.S.
-
effectivehealthcare-admin.ahrq.gov/products/antipsychotic-medicine-cardiovascular-elderly/research
March 18, 2009 - Reasons for using both drug groups (e.g., dementia, delirium) may themselves be risk factors for these … just new users to guard against selection bias among prevalent users from early symptom emergence, drug … models using propensity score adjustments to balance independent risk factors for outcomes between drug … Food and Drug Administration. … Available at: www.fda.gov/cder/drug/advisory/antipsychotics.htm . Accessed April 15, 2005.
2.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
December 01, 2015 - drug-
name=qsymia. … drug-name=xenical
http://www.goodrx.com/xenical?drug-name=xenical
http://www.goodrx.com/belviq? … drug-name=belviq
http://www.goodrx.com/belviq?drug-name=belviq
http://www.goodrx.com/contrave? … drug-name=contrave
http://www.goodrx.com/contrave?drug-name=contrave
http://www.goodrx.com/qsymia? … drug-name=qsymia
http://www.goodrx.com/qsymia?drug-name=qsymia
20
82. Aetna.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-mortality-elderly_research.pdf
March 01, 2009 - and more likely to exclude those who
discontinued the drug due to drug intolerance, or treatment failure … http://www.fda.gov/cder/drug/advisory/antipsychotics.htm
http://www.fda.gov/cder/drug/advisory/antipsychotics.htm … Drug Saf 2007;30(1):47-57.
35. Wehmeier PM, Heiser P, Remschmidt H. … Adverse Drug React Toxicol Rev
2002;21(4):189-203.
38. Fox CS, Evans JC, Larson MG, et al. … Antipsychotic drug use and mortality in older
adults with dementia.
-
effectivehealthcare-admin.ahrq.gov/products/retention-strategies-opioid-use-disorder/rapid-protocol
May 08, 2019 - Food and Drug Administration approved medications for OUD- methadone, buprenorphine, and extended-release … This rapid review, nominated by the Office of the Assistant Secretary for Health (OASH), Center for Drug … Food and Drug Administration (FDA), the Office of the Assistant Secretary for Mental Health and Substance … the Office of the Assistant Secretary for Planning and Evaluation (ASPE), the National Institute on Drug … Drug and Opioid-Involved Overdose Deaths - United States, 2013- 2017 .
-
effectivehealthcare-admin.ahrq.gov/products/patient-safety-telehealth/research
September 14, 2023 - Making Healthcare Safer IV: Active Infection Surveillance of Clostridioides difficile and Multi-Drug … | Sep 7, 2023
Making Healthcare Safer IV: Prevention of Transmission of Infection With Multi-Drug … Healthcare Safer IV: Opioid Stewardship
Rapid Evidence Product | Jan 16, 2024
Reducing Adverse Drug … | Feb 9, 2024
Computerized Clinical Decision Support To Prevent Medication Errors and Adverse Drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
January 01, 2012 - A drug for psychotic major depression, for which the U.S. … dosages or different drug regimens. … administration and is known to
be a street drug of abuse. … Research suggests new drug targets for
depression. … Washington (DC): Drug
Enforcement Administration, U.S.